Literature DB >> 163926

Identification of a viral protein involved in post-translational maturation of the encephalomyocarditis virus capsid precursor.

C Lawrence, R E Thach.   

Abstract

Translation of encephalomyocarditis virus RNA in a cell-free system from uninfected Krebs ascites cells results in the synthesis of a major polypeptide product with a molecular weight of approximately 112,000. In contrast, when the viral RNA is translated in a cell-free system from virus-infected cells, this polypeptide is absent and the largest polypeptide produced has a molecular weight of about 100,000. This latter polypeptide comigrates on sodium dodecyl sulfate-gels with in vivo virus capsid precursor A, and the two have identical patterns of CNBr-generated peptides. A polypeptide having a molecular weight of 12,500 is also a major translation product in the system from infected cells (but not from uninfected cells). This polypeptide appears to be generated by cleavage of the NH-2-terminal portion of the viral RNA-dependent polypeptides by a proteolytic activity present in the infected cell-free system. This proteolytic activity copurifies with the 23,000-molecular weight viral capsid protein gamma, found in infected cells, through chromatography on DEAE-cellulose and cellulose phosphate. This suggests that gamma is itself a proteolytic enzyme involved in maturation of the viral capsid precursor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163926      PMCID: PMC354537     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Characterization of the large picornaviral polypeptides produced in the presence of zinc ion.

Authors:  B E Butterworth; B D Korant
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

2.  Protein synthesis directed by encephalomyocarditis virus mRNA. 3. Discrete polypeptides translated from a monocistronic messenger in vitro.

Authors:  I Boime; P Leder
Journal:  Arch Biochem Biophys       Date:  1972-12       Impact factor: 4.013

3.  Virus-specific polypeptides in ascites cells infected with encephalomyocarditis virus.

Authors:  P Dobos; E M Martin
Journal:  J Gen Virol       Date:  1972-11       Impact factor: 3.891

4.  Kinetics of synthesis and cleavage of encephalomyocarditis virus-specific proteins.

Authors:  B E Butterworth; R R Rueckert
Journal:  Virology       Date:  1972-11       Impact factor: 3.616

5.  Protein synthesis directed by encephalomyocarditis virus RNA. II. The in vitro synthesis of high molecular weight proteins and elements of the viral capsid.

Authors:  I Boime; H Aviv; P Leder
Journal:  Biochem Biophys Res Commun       Date:  1971-11-05       Impact factor: 3.575

6.  Virus-specific proteins synthesized in encephalomyocarditis virus-infected HeLa cells.

Authors:  B E Butterworth; L Hall; C M Stoltzfus; R R Rueckert
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

7.  Gene order of encephalomyocarditis virus as determined by studies with pactamycin.

Authors:  B E Butterworth; R R Rueckert
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

8.  Characterization of the polypeptides formed in response to encephalomyocarditis virus ribonucleic acid in a cell-free system from mouse ascites tumor cells.

Authors:  I M Kerr; R E Brown; D R Tovell
Journal:  J Virol       Date:  1972-07       Impact factor: 5.103

9.  Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate.

Authors:  R T Swank; K D Munkres
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

10.  Encephalomyocarditis virus infection of mouse plasmacytoma cells. I. Inhibition of cellular protein synthesis.

Authors:  C Lawrence; R E Thach
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  17 in total

1.  Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing.

Authors:  D S Shih; C T Shih; D Zimmern; R R Rueckert; P Kaesberg
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

2.  Virus-specified protease in poliovirus-infected HeLa cells.

Authors:  B Korant; N Chow; M Lively; J Powers
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

3.  Protease required for processing picornaviral coat protein resides in the viral replicase gene.

Authors:  A C Palmenberg; M A Pallansch; R R Rueckert
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

4.  Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides.

Authors:  B D Korant; B E Butterworth
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

5.  Processing of mengovirus precursor polypeptides in the presence of zinc ions and sulfhydryl compounds.

Authors:  K Nakai; J Lucas-Lenard
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

6.  Cleavage of Rous sarcoma viral polypeptide precursor into internal structural proteins in vitro involves viral protein p15.

Authors:  K von der Helm
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  NMR structure of stem-loop D from human rhinovirus-14.

Authors:  Stephen J Headey; He Huang; Jolyon K Claridge; Giselle A Soares; Kaushik Dutta; Martin Schwalbe; Daiwen Yang; Steven M Pascal
Journal:  RNA       Date:  2006-12-28       Impact factor: 4.942

8.  Altered E2 glycoprotein of Sindbis virus and its use in complementation studies.

Authors:  M Bracha; M J Schlesinger
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

9.  Processing of the encephalomyocarditis virus capsid precursor protein studied in rabbit reticulocyte lysates incubated with N-formyl-[35S]methionine-tRNAfMet.

Authors:  E A Campbell; R J Jackson
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

10.  Inhibition of host translation in encephalomyocarditis virus-infected L cells: a novel mechanism.

Authors:  G Jen; R E Thach
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.